Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias

Circ Arrhythm Electrophysiol. 2011 Dec;4(6):947-57. doi: 10.1161/CIRCEP.111.964908. Epub 2011 Oct 18.

Abstract

Background: Digitalis-induced Na(+) accumulation results in an increase in Ca(2+)(i) via the Na(+)/Ca(2+) exchanger, leading to enhanced sarcoplasmic reticulum (SR) Ca(2+) load, responsible for the positive inotropic and toxic arrhythmogenic effects of glycosides. A digitalis-induced increase in Ca(2+)(i) could also activate calcium-calmodulin kinase II (CaMKII), which has been shown to have proarrhythmic effects. Here, we investigate whether CaMKII underlies digitalis-induced arrhythmias and the subcellular mechanisms involved.

Methods and results: In paced rat ventricular myocytes (0.5 Hz), 50 μmol/L ouabain increased contraction amplitude by 160 ± 5%. In the absence of electric stimulation, ouabain promoted spontaneous contractile activity and Ca(2+) waves. Ouabain activated CaMKII (p-CaMKII), which phosphorylated its downstream targets, phospholamban (PLN) (Thr17) and ryanodine receptor (RyR) (Ser2814). Ouabain-induced spontaneous activity was prevented by inhibiting CaMKII with 2.5 μmol/L KN93 but not by 2.5 μmol/L of the inactive analog, KN92. Similar results were obtained using the CaMKII inhibitor, autocamtide-2 related inhibitory peptide (AIP) (1 to 2.5 μmol/L), and in myocytes from transgenic mice expressing SR-targeted AIP. Consistently, CaMKII overexpression exacerbated ouabain-induced spontaneous contractile activity. Ouabain was associated with an increase in SR Ca(2+) content and Ca(2+) spark frequency, indicative of enhanced SR Ca(2+) leak. KN93 suppressed the ouabain-induced increase in Ca(2+) spark frequency without affecting SR Ca(2+) content. Similar results were obtained with digoxin. In vivo, ouabain-induced arrhythmias were prevented by KN93 and absent in SR-AIP mice.

Conclusions: These results show for the first time that CaMKII mediates ouabain-induced arrhythmic/toxic effects. We suggest that CaMKII-dependent phosphorylation of the RyR, resulting in Ca(2+) leak from the SR, is the underlying mechanism involved.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Arrhythmias, Cardiac / chemically induced*
  • Arrhythmias, Cardiac / diagnosis
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / prevention & control
  • Benzylamines / pharmacology
  • Calcium / metabolism
  • Calcium Signaling / drug effects*
  • Calcium-Binding Proteins / genetics
  • Calcium-Binding Proteins / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / genetics
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Cardiac Pacing, Artificial
  • Cardiotonic Agents / toxicity*
  • Cells, Cultured
  • Electrocardiography
  • Enzyme Activation
  • Heart Rate / drug effects*
  • Heart Ventricles / drug effects*
  • Heart Ventricles / enzymology
  • Heart Ventricles / physiopathology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Myocardial Contraction / drug effects
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / enzymology
  • Ouabain / toxicity*
  • Peptides / genetics
  • Peptides / metabolism
  • Peptides / pharmacology
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Rats
  • Rats, Wistar
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / enzymology
  • Sodium-Calcium Exchanger / metabolism
  • Sulfonamides / pharmacology
  • Time Factors
  • Transfection

Substances

  • Anti-Arrhythmia Agents
  • Benzylamines
  • CaMKII inhibitor AIP
  • Calcium-Binding Proteins
  • Cardiotonic Agents
  • Peptides
  • Protein Kinase Inhibitors
  • Ryanodine Receptor Calcium Release Channel
  • Sodium-Calcium Exchanger
  • Sulfonamides
  • phospholamban
  • KN 93
  • Ouabain
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium